NCT01423318View on ClinicalTrials.gov

A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Healthy Volunteer

Interventions

DRUG

lebrikizumab

Dose-level cohorts receiving single subcutaneous dose

DRUG

placebo

single dose subcutaneously

Trial Locations (1)

96813

Honolulu

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY